The Histone Variant MacroH2A1 Regulates Key Genes for Myogenic Cell Fusion in a Splice-Isoform Dependent Manner.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
30 04 2020
Historique:
received: 31 03 2020
revised: 21 04 2020
accepted: 23 04 2020
entrez: 6 5 2020
pubmed: 6 5 2020
medline: 17 3 2021
Statut: epublish

Résumé

MacroH2A histone variants have functions in differentiation, somatic cell reprogramming and cancer. However, at present, it is not clear how macroH2As affect gene regulation to exert these functions. We have parted from the initial observation that loss of total macroH2A1 led to a change in the morphology of murine myotubes differentiated ex vivo. The fusion of myoblasts to myotubes is a key process in embryonic myogenesis and highly relevant for muscle regeneration after acute or chronic injury. We have focused on this physiological process, to investigate the functions of the two splice isoforms of macroH2A1. Individual perturbation of the two isoforms in myotubes forming in vitro from myogenic C2C12 cells showed an opposing phenotype, with macroH2A1.1 enhancing, and macroH2A1.2 reducing, fusion. Differential regulation of a subset of fusion-related genes encoding components of the extracellular matrix and cell surface receptors for adhesion correlated with these phenotypes. We describe, for the first time, splice isoform-specific phenotypes for the histone variant macroH2A1 in a physiologic process and provide evidence for a novel underlying molecular mechanism of gene regulation.

Identifiants

pubmed: 32365743
pii: cells9051109
doi: 10.3390/cells9051109
pmc: PMC7290658
pii:
doi:

Substances chimiques

Chromatin 0
Histones 0
Macroh2a1 protein, mouse 0
Protein Isoforms 0
macroH2A histone 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

BMC Genomics. 2014 Jul 22;15:621
pubmed: 25051993
Nat Commun. 2018 Dec 3;9(1):5143
pubmed: 30510186
Nature. 1998 Jun 11;393(6685):599-601
pubmed: 9634239
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Epigenomics. 2012 Apr;4(2):221-7
pubmed: 22449192
Nat Struct Mol Biol. 2018 Oct;25(10):958-970
pubmed: 30291361
Cancers (Basel). 2018 Feb 27;10(3):
pubmed: 29495465
Nat Struct Mol Biol. 2014 Nov;21(11):981-9
pubmed: 25306110
Nat Rev Mol Cell Biol. 2017 May;18(5):299-314
pubmed: 28144029
Mol Cell Biol. 2012 Apr;32(8):1442-52
pubmed: 22331466
EMBO Rep. 2018 Oct;19(10):
pubmed: 30177554
Mol Cell. 2015 Sep 3;59(5):719-31
pubmed: 26300260
Cell Rep. 2013 Apr 25;3(4):1005-11
pubmed: 23545500
Cell Rep. 2018 Jul 3;24(1):224-237
pubmed: 29972783
Genes Dev. 2006 Dec 1;20(23):3324-36
pubmed: 17158748
Mol Cell Biol. 2007 Apr;27(7):2758-64
pubmed: 17242180
Genes Dev. 2001 Aug 15;15(16):2069-82
pubmed: 11511539
Nat Struct Mol Biol. 2017 Nov;24(11):902-910
pubmed: 28991266
Oncogene. 2009 Sep 24;28(38):3423-8
pubmed: 19648962
Mol Cell Biol. 2010 Dec;30(23):5473-83
pubmed: 20937776
Epigenetics. 2010 Feb 16;5(2):118-23
pubmed: 20160488
Genes Dev. 2010 Jan 1;24(1):21-32
pubmed: 20008927
Am J Pathol. 2012 Jun;180(6):2516-26
pubmed: 22542848
Nature. 2010 Dec 23;468(7327):1105-9
pubmed: 21179167
FASEB J. 2016 Aug;30(8):2708-19
pubmed: 27069062
Mol Cell Biol. 2005 Sep;25(17):7616-24
pubmed: 16107708
Epigenetics. 2009 Nov 16;4(8):541-50
pubmed: 20009536
EMBO J. 2011 May 06;30(12):2373-87
pubmed: 21552206
Cell. 2015 Dec 3;163(6):1333-47
pubmed: 26607792
Nat Struct Mol Biol. 2009 Sep;16(9):923-9
pubmed: 19680243
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nat Commun. 2013;4:1565
pubmed: 23463008
Nucleic Acids Res. 2018 Jul 2;46(W1):W503-W509
pubmed: 29800320
Mol Cell. 2003 Apr;11(4):1033-41
pubmed: 12718888
Bioinformatics. 2009 Aug 1;25(15):1952-8
pubmed: 19505939
Epigenetics Chromatin. 2010 Apr 01;3(1):8
pubmed: 20359320
Int J Cancer. 2016 Sep 1;139(5):1106-16
pubmed: 27074337
Cell Rep. 2016 Feb 9;14(5):1156-1168
pubmed: 26832413
Mol Metab. 2020 Aug;38:100950
pubmed: 32199820
EMBO J. 2007 Mar 7;26(5):1245-56
pubmed: 17304211
Cell Rep. 2015 May 19;11(7):1090-101
pubmed: 25959814
Nat Struct Mol Biol. 2005 Jul;12(7):624-5
pubmed: 15965484
Cells. 2019 Apr 09;8(4):
pubmed: 30970625
Nat Struct Mol Biol. 2009 Oct;16(10):1074-9
pubmed: 19734898
Nat Struct Mol Biol. 2012 Nov;19(11):1139-46
pubmed: 23022728
J Cell Sci. 2017 May 1;130(9):1570-1582
pubmed: 28283545
Nat Methods. 2017 Apr;14(4):417-419
pubmed: 28263959

Auteurs

Sarah Hurtado-Bagès (S)

Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-GTP-UAB, 08916 Badalona, Spain.

Melanija Posavec Marjanovic (M)

Program for Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), 08916 Badalona, Spain.

Vanesa Valero (V)

Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-GTP-UAB, 08916 Badalona, Spain.

Roberto Malinverni (R)

Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-GTP-UAB, 08916 Badalona, Spain.

David Corujo (D)

Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-GTP-UAB, 08916 Badalona, Spain.

Philippe Bouvet (P)

Université de Lyon, Ecole Normale Supérieure de Lyon, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, INSERM 1052, CNRS 5286, F-69008 Lyon, France.

Anne-Claire Lavigne (AC)

Center for Integrative Biology (CBI), LBME, University of Toulouse, UPS, CNRS, F-31062 Toulouse, France.

Kerstin Bystricky (K)

Center for Integrative Biology (CBI), LBME, University of Toulouse, UPS, CNRS, F-31062 Toulouse, France.

Marcus Buschbeck (M)

Cancer and Leukemia Epigenetics and Biology Program, Josep Carreras Leukaemia Research Institute (IJC), Campus ICO-GTP-UAB, 08916 Badalona, Spain.
Program for Predictive and Personalized Medicine of Cancer, Germans Trias i Pujol Research Institute (PMPPC-IGTP), 08916 Badalona, Spain.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH